用一个吸头彻底改变生物标记分析--将抗体与体积吸收式微型进样器耦合,实现灵敏的 LC-MS 分析

IF 5.2 Q1 CHEMISTRY, ANALYTICAL
Christina Johannsen, Léon Reubsaet, Trine Grønhaug Halvorsen
{"title":"用一个吸头彻底改变生物标记分析--将抗体与体积吸收式微型进样器耦合,实现灵敏的 LC-MS 分析","authors":"Christina Johannsen,&nbsp;Léon Reubsaet,&nbsp;Trine Grønhaug Halvorsen","doi":"10.1016/j.sampre.2024.100121","DOIUrl":null,"url":null,"abstract":"<div><p>The constant pursuit of efficient and cost-effective methods for analyzing human samples drives ongoing innovation in biomedical research. Introduced in 2014, Volumetric Absorptive Microsampling (VAMS) technology ensures fixed blood volume absorption and enhanced sample uniformity. Our study aims to enhance VAMS functionality by integrating sample preparation onto the device primarily used for sample collection. This involves the adsorption of antibodies onto VAMS tips, enabling instant sample clean-up at the time of sample collection. Using human chorionic gonadotropin (hCG) as a model analyte, we evaluated the qualitative and quantitative performance of Affinity-VAMS. First, we showed that adsorbing and covalently binding monoclonal antibodies to VAMS tips results in capturing of the target analyte in comparison to unmodified VAMS. Due to the ease of preparation, we moved forward using antibody adsorption to VAMS tip and optimized the procedure. Optimization of the procedure involved fine-tuning the antibody coupling step, washing process, and determining the optimal amount of antibody required, leading to a streamlined process with significant time savings up to two days. Recovery experiments demonstrate successful capture of the target analyte by the Affinity-VAMS, while matrix effects and stability assessments indicate no negative effects from serum matrix or storage conditions. Finally, quantitative analysis shows promising performance of the Affinity-VAMS in detecting different concentrations of the target analyte in the concentration range between 7.5 - 25 ng·mL<sup>−1</sup>. The calculated correlation factor was R<sup>2</sup> of 0.9988 and limit of detection 2.5 ng·mL<sup>−1</sup>. The precision lays within the ICH guidelines for bioanalytical method validation. While this report is focused on the proof of concept of the Affinity-VAMS, our findings demonstrate the potential for the usage of modified VAMS in remote sampling and integrated sample processing, enhancing biomarker analysis in clinical and research settings.</p></div>","PeriodicalId":100052,"journal":{"name":"Advances in Sample Preparation","volume":"11 ","pages":"Article 100121"},"PeriodicalIF":5.2000,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772582024000202/pdfft?md5=e494767b7410939e2ace08205a23f1ba&pid=1-s2.0-S2772582024000202-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Revolutionizing biomarker analysis one tip at a time—Coupling antibody to Volumetric Absorptive Microsamplers for sensitive LC-MS analysis\",\"authors\":\"Christina Johannsen,&nbsp;Léon Reubsaet,&nbsp;Trine Grønhaug Halvorsen\",\"doi\":\"10.1016/j.sampre.2024.100121\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The constant pursuit of efficient and cost-effective methods for analyzing human samples drives ongoing innovation in biomedical research. Introduced in 2014, Volumetric Absorptive Microsampling (VAMS) technology ensures fixed blood volume absorption and enhanced sample uniformity. Our study aims to enhance VAMS functionality by integrating sample preparation onto the device primarily used for sample collection. This involves the adsorption of antibodies onto VAMS tips, enabling instant sample clean-up at the time of sample collection. Using human chorionic gonadotropin (hCG) as a model analyte, we evaluated the qualitative and quantitative performance of Affinity-VAMS. First, we showed that adsorbing and covalently binding monoclonal antibodies to VAMS tips results in capturing of the target analyte in comparison to unmodified VAMS. Due to the ease of preparation, we moved forward using antibody adsorption to VAMS tip and optimized the procedure. Optimization of the procedure involved fine-tuning the antibody coupling step, washing process, and determining the optimal amount of antibody required, leading to a streamlined process with significant time savings up to two days. Recovery experiments demonstrate successful capture of the target analyte by the Affinity-VAMS, while matrix effects and stability assessments indicate no negative effects from serum matrix or storage conditions. Finally, quantitative analysis shows promising performance of the Affinity-VAMS in detecting different concentrations of the target analyte in the concentration range between 7.5 - 25 ng·mL<sup>−1</sup>. The calculated correlation factor was R<sup>2</sup> of 0.9988 and limit of detection 2.5 ng·mL<sup>−1</sup>. The precision lays within the ICH guidelines for bioanalytical method validation. While this report is focused on the proof of concept of the Affinity-VAMS, our findings demonstrate the potential for the usage of modified VAMS in remote sampling and integrated sample processing, enhancing biomarker analysis in clinical and research settings.</p></div>\",\"PeriodicalId\":100052,\"journal\":{\"name\":\"Advances in Sample Preparation\",\"volume\":\"11 \",\"pages\":\"Article 100121\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2024-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772582024000202/pdfft?md5=e494767b7410939e2ace08205a23f1ba&pid=1-s2.0-S2772582024000202-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Sample Preparation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772582024000202\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Sample Preparation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772582024000202","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

摘要

对高效、经济的人体样本分析方法的不断追求,推动着生物医学研究领域的持续创新。体积吸收微采样(VAMS)技术于 2014 年推出,可确保固定血容量吸收并提高样本均匀性。我们的研究旨在将样本制备集成到主要用于样本采集的设备上,从而增强 VAMS 的功能。这包括将抗体吸附到 VAMS 吸头上,以便在采集样本时立即进行样本清理。我们使用人绒毛膜促性腺激素(hCG)作为模型分析物,评估了 Affinity-VAMS 的定性和定量性能。首先,我们发现,与未经修饰的 VAMS 相比,将单克隆抗体吸附并共价结合到 VAMS 顶端可捕获目标分析物。由于制备简便,我们将抗体吸附到 VAMS 顶端,并对程序进行了优化。优化过程包括微调抗体偶联步骤、洗涤过程和确定所需的最佳抗体量,从而简化了过程,大大节省了时间,最多可节省两天。回收实验表明,Affinity-VAMS 能成功捕获目标分析物,而基质效应和稳定性评估表明,血清基质或储存条件不会产生负面影响。最后,定量分析显示,Affinity-VAMS 在检测 7.5 - 25 ng-mL-1 浓度范围内不同浓度的目标分析物方面表现良好。计算得出的相关系数 R2 为 0.9988,检测限为 2.5 ng-mL-1。精确度符合 ICH 生物分析方法验证指南的要求。虽然本报告的重点是 Affinity-VAMS 的概念验证,但我们的研究结果证明了在远程采样和综合样品处理中使用改良 VAMS 的潜力,从而加强了临床和研究环境中的生物标记分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Revolutionizing biomarker analysis one tip at a time—Coupling antibody to Volumetric Absorptive Microsamplers for sensitive LC-MS analysis

Revolutionizing biomarker analysis one tip at a time—Coupling antibody to Volumetric Absorptive Microsamplers for sensitive LC-MS analysis

The constant pursuit of efficient and cost-effective methods for analyzing human samples drives ongoing innovation in biomedical research. Introduced in 2014, Volumetric Absorptive Microsampling (VAMS) technology ensures fixed blood volume absorption and enhanced sample uniformity. Our study aims to enhance VAMS functionality by integrating sample preparation onto the device primarily used for sample collection. This involves the adsorption of antibodies onto VAMS tips, enabling instant sample clean-up at the time of sample collection. Using human chorionic gonadotropin (hCG) as a model analyte, we evaluated the qualitative and quantitative performance of Affinity-VAMS. First, we showed that adsorbing and covalently binding monoclonal antibodies to VAMS tips results in capturing of the target analyte in comparison to unmodified VAMS. Due to the ease of preparation, we moved forward using antibody adsorption to VAMS tip and optimized the procedure. Optimization of the procedure involved fine-tuning the antibody coupling step, washing process, and determining the optimal amount of antibody required, leading to a streamlined process with significant time savings up to two days. Recovery experiments demonstrate successful capture of the target analyte by the Affinity-VAMS, while matrix effects and stability assessments indicate no negative effects from serum matrix or storage conditions. Finally, quantitative analysis shows promising performance of the Affinity-VAMS in detecting different concentrations of the target analyte in the concentration range between 7.5 - 25 ng·mL−1. The calculated correlation factor was R2 of 0.9988 and limit of detection 2.5 ng·mL−1. The precision lays within the ICH guidelines for bioanalytical method validation. While this report is focused on the proof of concept of the Affinity-VAMS, our findings demonstrate the potential for the usage of modified VAMS in remote sampling and integrated sample processing, enhancing biomarker analysis in clinical and research settings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信